Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of contents:; History of Cancer Immunotherapy -- Section I: Basic Principles of Tumor Immunology -- Section II: Cancer Immunotherapy Targets and Classes -- Section III: Immune Function in Cancer Patients -- Section IV: Disease-Specific Treatments and Outcomes -- Section V: Regulatory Aspects …
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency SUR Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency CN Library Missing | Available | ||
c.2 BC Cancer Agency SUR Library | Available |
Contents:; 1: Basis of Carcinogenesis; 2: Epidemiology and Prevention; 3: Evidence-Based Nursing in Basic Anticancer Treatment: Management of the Most Important Side Effects; 4: The Patients? Journey with Targeted Therapies; 5: Immunotherapy: New Challenges for Nursing; 6: Robotic Surgery; 7: Relat…
Contents:; Cellular mechanisms of chemotherapy -- Pharmacologic principles of chemotherapy -- Pharmacogenomics and chemotherapy -- Principles and standards of antineoplastic therapy administration -- Administration of hazardous drugs in the perioperative setting -- Immunotherapy : agents and target…
Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients r…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency SUR Library Missing | Available | ||
c.2 BC Cancer Agency SUR Library | Available | ||
c.3 BC Cancer Agency VAN Library Missing | Available | ||
c.4 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.5 BC Cancer Agency VAN Library Missing | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.2 BC Cancer Agency ARHCC Library Missing | Available | ||
c.3 BC Cancer Agency ARHCC Library | Available | ||
c.2 BC Cancer Agency CN Library | Available | ||
c.3 BC Cancer Agency CN Library | Available | ||
c.3 BC Cancer Agency KEL Library | Available | ||
c.3 BC Cancer Agency SUR Library | Available | ||
c.2 BC Cancer Agency VIC Library Missing | Available | ||
c.4 BC Cancer Agency VIC Library | Available | ||
c.5 BC Cancer Agency VIC Library | Available | ||
c.5 BC Cancer Agency SUR Library | Available | ||
c.4 BC Cancer Agency KEL Library | On Loan, due Wednesday, May 15, 2024 | ||
c.1 BC Cancer Agency VAN Library | On Loan, due Tuesday, June 11, 2024 | ||
c.2 BC Cancer Agency VAN Library | On Loan, due Thursday, May 23, 2024 | ||
c.2 BC Cancer Agency KEL Library | On Loan, due Monday, June 17, 2024 | ||
c.4 BC Cancer Agency SUR Library | On Loan, due Monday, June 10, 2024 | ||
c.3 BC Cancer Agency VIC Library | On Loan, due Wednesday, June 5, 2024 | ||
c.5 BC Cancer Agency KEL Library | On Loan, due Monday, March 25, 2024 |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.2 BC Cancer Agency KEL Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available |
Table of Contents:; Chapter 1 -- Translation in Immunology: The Role of Translational Biomarkers to Guide Clinical Use of Immunotherapy for Cancer -- Chapter 2 Monoclonal Antibody Therapy -- Chapter 3 Somatic Mutations and Immunotherapy -- Chapter 4 Checkpoint Blockade -- Chapter 5 Myeloid Leukemia…
The combined effects of population growth and aging have led to an increase in the number of cancers. Preventing, diagnosing, treating and curing cancer are therefore, more than ever, imperatives facing medicine ? especially to continue the decrease in cancers' mortality rates and to improve the qu…